| Financial Year |
March 31 2023 |
| Monetary Funds |
486,911,633.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,835,331.92 |
| Accounts Receivable |
505,886,730.27 |
| Advances to Suppliers |
13,147,242.90 |
| Other Receivables |
52,577,697.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
358,136,265.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
465,660,860.11 |
| Total Current Assets |
1,933,571,749.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
32,866,378.26 |
| Fixed Assetes |
128,544,502.20 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,944,997.18 |
| R&D expenses |
96,158,118.05 |
| Goodwill |
29,682,325.82 |
| Long-Term Deferred and Prepaid Expenses |
10,679,709.10 |
| Deferred Income Tax Assets |
40,512,127.14 |
| Other Non-Current Assets |
4,544,720.00 |
| Sub-Total of Non-Current Assets |
561,526,912.64 |
| Total Assets |
2,495,098,662.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
143,372,801.19 |
| Accounts Received In Advance |
2,454.41 |
| Employee Compensation Payable |
86,348,415.22 |
| Taxes Payable |
7,718,813.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,637,177.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,775,577.64 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
735,636,768.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,268,377.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,706,409.86 |
| Total Liabilities |
796,343,177.93 |
| Paid-In Capital(Or Share Stock) |
408,231,038.00 |
| Capital Surplus |
313,619,859.35 |
| Surplus Reserve |
117,363,636.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
720,467,919.09 |
| Minority Stockholder's Interest |
139,073,031.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,559,682,453.13 |
| Owner's Equity（Stockholder's Equity） |
1,698,755,484.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,495,098,662.17 |
